Correction: antibiotics in the clinical pipeline as of december 2022

Correction to: _The Journal of Antibiotics_ https://doi.org/10.1038/s41429-023-00629-8 published online 08 June 2023 The authors of the above article have noticed that prodrug contezolid

acefosamil (3) was incorrectly stated as being approved rather than contezolid (4). This has been corrected throughout the review. The changes are below: In the sentence in the third

paragraph of the introduction beginning “The new antibacterial drugs approved since the previous 2019 review…”, “contezolid acefosamil (3)” should have been “contezolid (4)”. In Table 1, the

drug name “contezolid acefosamil (3) (prodrug)” should have been “contezolid (4)”, without “(prodrug)”. In the sentence beginning “Since the 2019 review…”, in paragraph 2 of the section

“Antibacterial drugs launched from January 2013 to December 2022”, “contezolid acefosamil (3)” should have been “contezolid (4)”. In the fourth paragraph of the section “Antibacterial drugs

launched from January 2013 to December 2022”, several changes have been made. In the first sentence, “Contezolid acefosamil (3)” has been changed to “Contezolid (4)”, “(Youxitai, MRX-4, po)”

has been changed to “(Youxitai, MRX-1, IV)”, and the word “prodrug” has been removed. In the third sentence, “(MRX-1)” has been removed, and “3” has been changed to “contezolid acefosamil

(3)”. In the fourth sentence, “The prodrug” has been changed to “The prodrug 3”. In the “Conclusion and outlook” section, in the sentence beginning “There were only two new small molecule

antibacterial drugs…”, “the oxazolidinone contezolid acefosamil (3)” should have read “the oxazolidinone contezolid (4)”. In addition, there was also an error in the “New antibacterial

pharmacophore analysis” section where it was stated that gepotidacin (10) inhibited GyrB and not GyrA. The mode of action of gepotidacin (10) is correctly described elsewhere in the review.

GyrB has been corrected to GyrA. The original article has been corrected. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Centre for Superbug Solutions, Institute for Molecular Bioscience, The

University of Queensland, St Lucia, Brisbane, QLD, 4072, Australia Mark S. Butler, Ian R. Henderson, Robert J. Capon & Mark A. T. Blaskovich Authors * Mark S. Butler View author

publications You can also search for this author inPubMed Google Scholar * Ian R. Henderson View author publications You can also search for this author inPubMed Google Scholar * Robert J.

Capon View author publications You can also search for this author inPubMed Google Scholar * Mark A. T. Blaskovich View author publications You can also search for this author inPubMed 

Google Scholar CORRESPONDING AUTHORS Correspondence to Mark S. Butler or Mark A. T. Blaskovich. RIGHTS AND PERMISSIONS OPEN ACCESS This article is licensed under a Creative Commons

Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original

author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the

article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use

is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit

http://creativecommons.org/licenses/by/4.0/. Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Butler, M.S., Henderson, I.R., Capon, R.J. _et al._ Correction: Antibiotics in the

clinical pipeline as of December 2022. _J Antibiot_ 77, 71 (2024). https://doi.org/10.1038/s41429-023-00671-6 Download citation * Published: 07 November 2023 * Issue Date: January 2024 *

DOI: https://doi.org/10.1038/s41429-023-00671-6 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is

not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative